Managers / Q3 2023 · view latest →
DSC Advisors, L.P.
CIK 0001299434 · 900 NORTH MICHIGAN AVENUE, SUITE 1600, CHICAGO, IL, 60611 · (312) 915-2485
Summary
Dsc Advisors, L.P. reported $78M in U.S.-listed holdings across 33 positions for Q3 2023.
Its largest position, CVS, represents 17.7% of the portfolio.
Compared with Q2 2023, the fund opened 5 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 94.7% · $74M
- ADR · 3.8% · $3M
- ETP · 1.1% · $853,300
- Other · 0.4% · $321,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| UNITED STS NAT GAS FD LP | NEW | +100.0K | 100.0K | +$683,000 | $683,000 |
| THE ODP CORP | NEW | +10.0K | 10.0K | +$461,500 | $461,500 |
| ADTADT INC DEL | NEW | +30.0K | 30.0K | +$180,000 | $180,000 |
| JETSETF SER SOLUTIONS | NEW | +10.0K | 10.0K | +$170,300 | $170,300 |
| GENIGENIUS SPORTS LIMITED | NEW | +30.0K | 30.0K | +$159,900 | $159,900 |
| EHABUSDENHABIT INC | ADDED | +115.5K | 125.5K | +$1M | $1M |
| VIVID SEATS INC | ADDED | +40.0K | 50.0K | +$241,800 | $321,000 |
| ABTABBOTT LABS | ADDED | +64.3K | 105.7K | +$6M | $10M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CVSCVS HEALTH CORPhistory → | COM | 17.68% | $14M | 197.2K |
| 2 | R1 RCM INC | COM | 16.27% | $13M | 841.0K |
| 3 | BMRNBIOMARIN PHARMACEUTICAL INChistory → | COM | 11.36% | $9M | 100.0K |
| 4 | ZBHZIMMER BIOMET HOLDINGS INChistory → | COM | 9.33% | $7M | 64.7K |
| 5 | ABTABBOTT LABShistory → | COM | 8.66% | $7M | 69.7K |
| 6 | GOOGALPHABET INC | CAP STK CL C · CAP STK CL A | 8.26% | $6M | 48.8K |
| 7 | EHTHEHEALTH INChistory → | COM | 3.90% | $3M | 410.0K |
| 8 | TEVATEVA PHARMACEUTICAL INDS LTDhistory → | SPONSORED ADS | 3.83% | $3M | 292.5K |
| 9 | EHABUSDENHABIT INChistory → | COM | 1.05% | $815,625 | 72.5K |
| 10 | THE ODP CORP | COM | 0.59% | $461,500 | 10.0K |
| 11 | VYNEVYNE THERAPEUTICS INC | COM | 0.59% | $460,000 | 115.0K |
| 12 | MSFTMICROSOFT CORP | COM | 0.48% | $372,269 | 1.2K |
| 13 | METAMETA PLATFORMS INC | CL A | 0.46% | $360,252 | 1.2K |
| 14 | VIVID SEATS INC | COM CL A | 0.41% | $321,000 | 50.0K |
| 15 | VVISA INC | COM CL A | 0.38% | $294,873 | 1.3K |
| 16 | MAMASTERCARD INCORPORATED | CL A | 0.38% | $293,369 | 741 |
| 17 | ADBEADOBE INC | COM | 0.34% | $261,579 | 513 |
| 18 | ACNACCENTURE PLC IRELAND | SHS CLASS A | 0.32% | $252,752 | 823 |
| 19 | CRMSALESFORCE INC | COM | 0.32% | $252,056 | 1.2K |
| 20 | BRK/BBERKSHIRE HATHAWAY INC DEL | CL B NEW | 0.30% | $233,650 | 667 |
| 21 | AAPLAPPLE INC | COM | 0.27% | $208,363 | 1.2K |
| 22 | ORCLORACLE CORP | COM | 0.26% | $205,908 | 1.9K |
| 23 | ADTADT INC DEL | COM | 0.23% | $180,000 | 30.0K |
| 24 | JETSETF SER SOLUTIONS | US GLB JETS | 0.22% | $170,300 | 10.0K |
| 25 | GENIGENIUS SPORTS LIMITED | SHARES CL A | 0.21% | $159,900 | 30.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $11M | 19 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $30M | 24 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $63M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $61M | 32 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $78M | 33 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $67M | 31 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $115M | 24 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $44M | 17 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $97M | 97 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $100M | 113 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $290M | 132 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $129M | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $98M | 74 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $138M | 74 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $161M | 85 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $121M | 51 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $149M | 49 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $91M | 37 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $102M | 35 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 88 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $506M | 97 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $569M | 85 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $544M | 81 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $826M | 78 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DSCQG PR LLC028-18129
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.